Astellas, Israel’s Teva Settle U.S. Patent Suit Over Bladder Drug
This article was originally published in PharmAsia News
Executive Summary
Astellas Pharma and Teva Pharmaceutical Industries of Israel have settled the Japanese company's U.S. patent infringement suit over Vesicare (solifenacin)